CHPA recognizes 2026 U.S. Self-Care Marketing
At its annual Philadelphia gala, the Health In Hand Foundation honored leading OTC marketing campaigns in six categories.
CHPA
Consumers back expanded HSA and FSA eligibility for oral care
A CHPA survey found 83% of HSA and FSA holders would use healthcare savings for everyday oral care if eligible, supporting proposed coverage-expansion legislation.
Supplement groups urge NIH to retain ODS independence
The groups warned that the change could weaken ODS’s scientific role, add bureaucracy, and diminish its ability to fulfill its congressional mandate.
CHPA expands membership with 14 new companies
“These companies reflect the breadth of self-care options available to consumers today and the diverse industry CHPA is proud to represent."
CHPA welcomes Wysong’s appointment as NACDS chief
Melville: “Mike is a champion of industry and a passionate leader; I know he will be outstanding in this new role.”
CHPA honors Julie Aker for work advancing OTC medicines
“Julie has been at the center of some of the most important OTC switches of the past several decades, helping shape the science that gives regulators confidence and consumers greater access to self-care products.”
CHPA issues statement on California AB 230
"CHPA is disappointed that AB 2030, as signed into law, does not strike a better balance between our shared goal of protecting minors and preserving access to safe, beneficial products for adults who use them responsibly."
Supplement groups back drug preclusion reform bill
CHPA, AHPA and CRN say the legislation would clarify FDA drug preclusion rules and provide greater regulatory certainty for dietary supplements.
CHPA names 2026 Self-Care Marketing Awards finalists
Winners across six self-care marketing categories will be announced November 11 at the Health In Hand Foundation Gala in Philadelphia.
CHPA president and CEO Scott Melville to step down
Scott Melville will conclude a 16-year tenure during which CHPA expanded its reach across the broader self-care industry.
CHPA issues statement on nomination of Dr. Heidi Overton
"We are pleased the Administration is moving quickly to appoint a permanent leader of the FDA. Stable, science-based leadership is essential to a smooth-functioning FDA.”
CHPA and CBA push back against regulatory moves on food definitions and ingredient reviews
Both groups warning that the government's approach risks confusing consumers and disrupting product availability without a clear scientific basis.
CHPA marks International Self-Care Day
CHPA said self-care interventions save an estimated 1.3 billion hours and $31.8 billion in healthcare-related costs annually across North America.
CHPA welcomes Missouri law expanding OTC cold and allergy med access
New law raises the annual purchase limit for pseudoephedrine products while maintaining safeguards against misuse.
CHPA names new chair-elect and board members
“CHPA is fortunate to have exceptional industry leaders volunteer their time to help direct the association’s priorities and oversee its governance,” said Scott Melville, President and CEO of CHPA.
CHPA calls for FDA stability after Makary departure
The trade association said that the pace of leadership turnover at the FDA over the past year has created uncertainty among industry stakeholders.